Chlorthalidone for Hypertension and Edema Management
Introduction to Chlorthalidone
- The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend chlorthalidone as the preferred thiazide diuretic due to its prolonged half-life and proven reduction of cardiovascular disease in landmark clinical trials 1, 2
Dosing and Administration
- The American Academy of Pediatrics recommends starting with chlorthalidone 0.3 mg/kg per day with a maximum of 2 mg/kg per day up to 50 mg/day in children, given once daily 5
- The initial dose for adults is 12.5 mg once daily, with titration to 25 mg once daily if blood pressure target is not achieved within 2-4 weeks 2, 4
Combination Therapy
- The ACC/AHA guidelines recommend chlorthalidone as useful add-on therapy with drugs from other classes, making it ideal for combination with ACE inhibitors, ARBs, or calcium channel blockers 5, 3
- For Stage 2 hypertension, initiate combination therapy immediately with two agents from different classes, such as telmisartan 40 mg plus chlorthalidone 12.5 mg once daily 3
Special Populations
- In patients with advanced chronic kidney disease (eGFR <30 mL/min/1.73 m²), chlorthalidone is specifically superior to hydrochlorothiazide in reducing 24-hour ambulatory blood pressure 2
- Chlorthalidone is effective as first-line therapy in diabetic patients, though it may cause small increases in fasting glucose 1
Monitoring and Adverse Effects
- The ACC/AHA guidelines recommend monitoring serum potassium, sodium, creatinine/eGFR, uric acid, and fasting glucose in patients taking chlorthalidone 2, 3, 1
- Hypokalemia is the most significant concern, with risk increasing with dose and duration of therapy, and can contribute to ventricular ectopy and possible sudden death 2, 4
Clinical Pitfalls to Avoid
- Do not combine chlorthalidone with potassium-sparing diuretics when also using ACE inhibitors or ARBs, as this may cause severe hyperkalemia 5
- Do not assume chlorthalidone and hydrochlorothiazide are interchangeable, as chlorthalidone has superior cardiovascular outcomes and longer duration of action 2